Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents.
Styczynski J, Tallamy B, Waxman I, van de Ven C, Milone MC, Shaw LM, Harrison L, Morris E, Satwani P, Bhatia M, George D, Bradley MB, Garvin JH, Schwartz J, Baxter-Lowe LA, Cairo MS. Styczynski J, et al. Among authors: milone mc. Bone Marrow Transplant. 2011 Jun;46(6):790-9. doi: 10.1038/bmt.2010.209. Epub 2010 Sep 6. Bone Marrow Transplant. 2011. PMID: 20818441 Clinical Trial.
The pharmacokinetics and safety of twice daily i.v. BU during conditioning in pediatric allo-SCT recipients.
Le Gall JB, Milone MC, Waxman IM, Shaw LM, Harrison L, Duffy D, van de Ven C, Militano O, Geyer MB, Morris E, Bhatia M, Satwani P, George D, Garvin JH, Bradley MB, Schwartz J, Baxter-Lowe LA, Cairo MS. Le Gall JB, et al. Among authors: milone mc. Bone Marrow Transplant. 2013 Jan;48(1):19-25. doi: 10.1038/bmt.2012.105. Epub 2012 Jun 11. Bone Marrow Transplant. 2013. PMID: 22684047 Clinical Trial.
Pharmacokinetic targeting of i.v. BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time curve on transplant-related outcomes.
Perkins J, Field T, Kim J, Kharfan-Dabaja MA, Ayala E, Perez L, Fernandez H, Fancher K, Tate C, Shaw LM, Milone MC, Gardiner JA, Miller S, Anasetti C. Perkins J, et al. Among authors: milone mc. Bone Marrow Transplant. 2011 Nov;46(11):1418-25. doi: 10.1038/bmt.2010.315. Epub 2010 Dec 6. Bone Marrow Transplant. 2011. PMID: 21132026
Therapeutic drug monitoring of mycophenolic acid.
Shaw LM, Figurski M, Milone MC, Trofe J, Bloom RD. Shaw LM, et al. Among authors: milone mc. Clin J Am Soc Nephrol. 2007 Sep;2(5):1062-72. doi: 10.2215/CJN.03861106. Epub 2007 Aug 16. Clin J Am Soc Nephrol. 2007. PMID: 17702714 Review. No abstract available.
Removal of gadolinium by peritoneal dialysis.
Murashima M, Drott HR, Carlow D, Shaw LM, Milone M, Bachman M, Tsai DE, Yang SL, Bloom RD. Murashima M, et al. Clin Nephrol. 2008 May;69(5):368-72. doi: 10.5414/cnp69368. Clin Nephrol. 2008. PMID: 18538100
116 results